BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38130498)

  • 1. Optimization of Thromboprophylaxis Use in Hospitalized Pediatric Patients Through Implementation of a Venous Thromboembolism Risk Assessment Tool.
    Sanchez A; Campanella L; Perez K
    J Pediatr Pharmacol Ther; 2023; 28(5):452-456. PubMed ID: 38130498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing pharmacologic thromboprophylaxis use in pediatric orthopedic surgical patients through implementation of a perioperative venous thromboembolism risk screening tool.
    MacNevin W; Padhye K; Alkhalife Y; Price V; El-Hawary R; Branchford BR; Stevens S; Kulkarni K
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28803. PubMed ID: 33219749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
    McLaughlin HD; Greco P; Straubhar AM; Rolston A; McCool K; Brackmann M; Siedel JH; McLean K; Reynolds RK; Uppal S
    Gynecol Oncol; 2023 Nov; 178():89-95. PubMed ID: 37832182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study.
    Kemp M; Chan AHY; Harrison J; Rogers H; Zhao A; Kaur H; Tang G; Yang E; Beyene K
    Int J Clin Pharm; 2023 Aug; 45(4):864-874. PubMed ID: 37074512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil.
    Deheinzelin D; Braga AL; Martins LC; Martins MA; Hernandez A; Yoshida WB; Maffei F; Monachini M; Calderaro D; Campos W; Sguizzatto GT; Caramelli B;
    J Thromb Haemost; 2006 Jun; 4(6):1266-70. PubMed ID: 16706970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Quality and Safety of Venous Thromboembolism Prophylaxis Among Gastroenterology Inpatients at a Tertiary Hospital in Australia.
    van Oosterom N; De Guzman KR; Winckel K; Johnson A; Falconer N
    Hosp Pharm; 2023 Dec; 58(6):595-604. PubMed ID: 38560547
    [No Abstract]   [Full Text] [Related]  

  • 9. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
    Wehmeyer A; Coetzee R; McCartney J
    S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.
    Pandor A; Horner D; Davis S; Goodacre S; Stevens JW; Clowes M; Hunt BJ; Nokes T; Keenan J; de Wit K
    Health Technol Assess; 2019 Dec; 23(63):1-190. PubMed ID: 31851608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
    Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
    Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life use of thromboprophylaxis in patients hospitalized for pulmonary disorders: A single-center retrospective study.
    Łukaszuk RF; Plens K; Undas A
    Adv Clin Exp Med; 2018 Feb; 27(2):237-243. PubMed ID: 29521068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: A real life experience.
    Mahlab-Guri K; Otman MS; Replianski N; Rosenberg-Bezalel S; Rabinovich I; Sthoeger Z
    Medicine (Baltimore); 2020 Feb; 99(7):e19127. PubMed ID: 32049830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk stratification and adherence to venous thromboembolism prophylaxis among hospitalized obstetric women: Retrospective case file review at East Jeddah Hospital during 2018-2019.
    Mattar G; Al Sahafi N; Al Hazmi L; Al Hazmi N; Abozeid HE; Sultan I
    Ann Thorac Med; 2022; 17(2):94-101. PubMed ID: 35651894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness.
    Goldenberg NA; Sochet A; Albisetti M; Biss T; Bonduel M; Jaffray J; MacLaren G; Monagle P; O'Brien S; Raffini L; Revel-Vilk S; Sirachainan N; Williams S; Zia A; Male C;
    J Thromb Haemost; 2020 Nov; 18(11):3099-3105. PubMed ID: 33174388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a provider-enhanced clinical decision support tool for guiding venous thromboembolism pharmacoprophylaxis in low-risk patients.
    MaCauley MJ; Showalter JW; Beck MJ; Chuang CH
    Hosp Pract (1995); 2012 Aug; 40(3):7-12. PubMed ID: 23086089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model-Guided Decision-Making for Thromboprophylaxis and Hospital-Acquired Thromboembolic Events Among Hospitalized Children and Adolescents: The CLOT Randomized Clinical Trial.
    Walker SC; French B; Moore RP; Domenico HJ; Wanderer JP; Mixon AS; Creech CB; Byrne DW; Wheeler AP
    JAMA Netw Open; 2023 Oct; 6(10):e2337789. PubMed ID: 37831448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.